Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
about
Contralateral prophylactic mastectomy: current perspectivesThe impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.Risk of asynchronous contralateral breast cancer: multiple approaches for a complex issue.Cost of contralateral prophylactic mastectomyBetter contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomyContralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.Bilateral Mastectomy for Unilateral Breast Cancer: a Perplexing TrendContralateral Prophylactic Mastectomy: Challenging Considerations for the SurgeonImmediate reconstruction following nipple-sparing mastectomy: one option for young breast cancer patients with early stage diseaseEstablishing a program for individuals at high risk for breast cancer.Bilateral breast cancers.Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.Survival Outcomes and Pathologic Features Among Breast Cancer Patients Who Have Developed a Contralateral Breast Cancer.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.Re: Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.Challenges in breast cancer management and prevention.Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
P2860
Q26744320-DB4EFBB5-07D2-490E-BF2A-62FD18B45E0FQ30677729-B464DBC0-8820-43DC-9439-779D15F0555DQ30692732-C5FC19B6-E613-4652-9DB3-0FF30D21024BQ31118195-9C6035A3-4E53-4C74-A369-A54A3F4E0B81Q33972981-95DAD8C4-E127-4337-B788-E413F6383558Q34017128-B718ED0C-2B83-4AEE-9810-1F369A9499A7Q35073191-C9E2630C-A3D1-401D-BF0F-0FF455A4FD6FQ35850183-CDC1BD74-FBD7-4BFB-A348-E7E0ED25F127Q36734744-A7584049-0A88-468E-B8E7-3FD0CCBE4FADQ36812287-2F0956EF-C5CA-45D3-8309-2AED63CE54C5Q36973006-CE188E19-E41E-4BD7-A3B8-217DE1618C56Q36983389-BEED55CF-DE57-4E8F-8D92-051452E76361Q38184906-17E03CA7-5353-40CF-90F8-44C47E20182EQ38206470-B5E26EA0-AD7F-4FC7-B622-5FF84DB737CBQ38738100-55302899-CE4B-48A3-AE55-55246D451A30Q38967974-5E0A7C82-F58F-4345-A5B4-4831DA5D2434Q39033804-2222BEBF-ACA8-49CD-81C7-D7B235128E6CQ39150355-0DD83173-D6D7-4AC6-B2C9-0F96EE51EDAAQ40758851-737A646B-BF75-45D6-A3E6-1F16F2FBD9CEQ43507790-0EFACE4E-0C92-489C-82A2-7B503F1B3873Q46041299-943E4F3D-1393-4332-A13F-14FFB4EB874DQ46044304-C84CD51E-032C-4E37-A4AA-D723FC5381FCQ46442172-B87A4FAD-AD9E-4A9D-9C77-D4643B972AB1Q51068059-A6C302B2-A55E-499B-8C74-72C332A3C245Q55437668-0E1CF9BB-892B-4D77-A4D6-D85BB1712F43
P2860
Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Association between contralate ...... es by hormone receptor status.
@ast
Association between contralate ...... es by hormone receptor status.
@en
type
label
Association between contralate ...... es by hormone receptor status.
@ast
Association between contralate ...... es by hormone receptor status.
@en
prefLabel
Association between contralate ...... es by hormone receptor status.
@ast
Association between contralate ...... es by hormone receptor status.
@en
P2093
P2860
P356
P1433
P1476
Association between contralate ...... es by hormone receptor status.
@en
P2093
Abenaa M Brewster
Isabelle Bedrosian
Melissa Crosby
Patricia A Parker
Susan K Peterson
Wenli Dong
P2860
P304
P356
10.1002/CNCR.27574
P407
P577
2012-04-19T00:00:00Z